Venovenous ECMO

DEVICE3 trials

Sponsors

University of Toronto, Australian and New Zealand Intensive Care Research Centre, University of Michigan

Conditions

ARDSAcute Respiratory Distress Syndrome Due to COVID-19COVID-19 Respiratory InfectionExtracorporeal Membrane OxygenationHypoxemiaMechanical Ventilation ComplicationPneumoniaRespiratory Failure

Unknown Phase

Ultra-Low Tidal Volume Mechanical Ventilation in ARDS Through ECMO

University of TorontoARDS

Start: 2021-06-30End: 2023-12-31Target: 72Updated: 2021-04-06

Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure

RecruitingNCT05562505

Australian and New Zealand Intensive Care Research CentreAcute Respiratory Distress Syndrome Due to COVID-19, COVID-19 Respiratory Infection, Extracorporeal Membrane Oxygenation +3

Start: 2022-11-28End: 2027-01-31Target: 140Updated: 2024-08-09

Impact of Cannulation Strategy on Neurologic Injury in Infants With Respiratory Failure

CompletedNCT06079034

University of MichiganRespiratory Failure

Start: 2023-10-18End: 2023-12-12Updated: 2024-04-04